Montréal, July 29, 2020 - On July 28 and 29, 2020, the Fonds de solidarité FTQ sold 519,863 NASDAQ-listed common shares of Milestone Pharmaceuticals Inc. (the “Company”), representing approximately 2.11% of the outstanding shares.
Just prior to the sale, the Fonds de solidarité FTQ beneficially owned 2,774,783 common shares, representing approximately 11.27% of the Company’s outstanding shares. Immediately after the sale, the Fonds de solidarité FTQ beneficially owned 2,254,920 common shares, representing approximately 9.16% of the Company’s outstanding shares.
The shares were sold as part of the Fonds’ investment strategy. This investment will be periodically reviewed and the holding may be increased or decreased as necessary.
An early warning report will be filed on SEDAR (www.sedar.com) under the Company’s profile. To obtain a copy of the report, contact Natacha Bernier at (514) 708-2923. The Company’s head office is located at 1111 Dr. Frederik-Philips Boulevard, Suite 420, Montréal, Québec, H4M 2X6.
About Fonds de solidarité FTQ
Fonds de solidarité FTQ is a capital development fund that channels the savings of Quebecers into investments. With net assets of $13.8 billion as at May 31, 2020, the Fonds supported 221,267 jobs. The Fonds has 3,329 partner companies and 707,935 shareholders-savers. For more information, visit www.fondsftq.com.
- 30 -